Personal information

No personal information available

Activities

Collapse all

Works (16)

New Treatment Regimens, New Drugs, and New Treatment Goals for Lupus Nephritis

Journal of Clinical Medicine
2025-01-17 | Journal article
DOI: 10.3390/jcm14020584
Contributors: Giovanni M. Rossi; Augusto Vaglio
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The Controversial Role of Glucocorticoids in Atheroembolic Renal Disease: A Narrative Review

Journal of Clinical Medicine
2024-10-27 | Journal article
DOI: 10.3390/jcm13216441
Contributors: Maria Chiara Pacchiarini; Francesca Di Mario; Paolo Greco; Enrico Fiaccadori; Giovanni Maria Rossi
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab

Journal of Nephrology
2023-10-17 | Journal article
DOI: 10.1007/s40620-023-01789-4
Contributors: Chiara Pala; Elisabetta Parenti; Giuseppe Vizzini; Davide Gianfreda; Giovanni Maria Rossi
Source: check_circle
Crossref

A Comparative Analysis of Nutritional Assessment Using Global Leadership Initiative on Malnutrition Versus Subjective Global Assessment and Malnutrition Inflammation Score in Maintenance Hemodialysis Patients

Journal of Renal Nutrition
2022-07 | Journal article
DOI: 10.1053/j.jrn.2021.06.008
Contributors: Carla Maria Avesani; Alice Sabatino; Alessandro Guerra; Juliana Rodrigues; Juan Jesus Carrero; Giovanni Maria Rossi; Giacomo Garibotto; Peter Stenvinkel; Enrico Fiaccadori; Bengt Lindholm
Source: check_circle
Crossref

Atheroembolic renal disease associated with dabigatran overdose

Journal of Nephrology
2022-04 | Journal article
DOI: 10.1007/s40620-021-01158-z
Contributors: Maria Chiara Pacchiarini; Giuseppe Vizzini; Chiara Italiano; Enrico Fiaccadori; Giovanni Maria Rossi
Source: check_circle
Crossref

Atypical hemolytic uremic syndrome complicating relapsing cryoglobulinemic membranoproliferative glomerulonephritis despite hepatitis C eradication

Journal of Nephrology
2022-01 | Journal article
DOI: 10.1007/s40620-021-00998-z
Contributors: Micaela Gentile; Giovanni Maria Rossi; Marco Delsante; Cristina Zambrano; Alessio Di Maria; Enrico Fiaccadori; Lucio Manenti
Source: check_circle
Crossref

Kidney Involvement in COVID-19: Need for Better Definitions

Journal of the American Society of Nephrology
2020-09 | Journal article
DOI: 10.1681/ASN.2020050630
Contributors: Marco Delsante; Giovanni M. Rossi; Ilaria Gandolfini; Serena M. Bagnasco; Avi Z. Rosenberg
Source: check_circle
Crossref

A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis.

The Journal of allergy and clinical immunology
2018-08 | Journal article
DOI: 10.1016/j.jaci.2018.06.045
PMID: 30081155
Contributors: Martorana D; Márquez A; Carmona FD; Bonatti F; Adorni A; Urban ML; Maritati F; Accorsi Buttini E; Marvisi C; Palmisano A et al.
Source: Self-asserted source
Giovanni M. Rossi via Europe PubMed Central

Hemoptysis in Behçet's syndrome: from bedside to bench?

Internal and emergency medicine
2018-05 | Journal article
DOI: 10.1007/s11739-018-1863-5
PMID: 29736629
Contributors: Rossi GM; Emmi G; Vaglio A
Source: Self-asserted source
Giovanni M. Rossi via Europe PubMed Central

Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease

Internal and Emergency Medicine
2017 | Journal article
DOI: 10.1007/s11739-016-1599-z
EID:

2-s2.0-85008701917
Contributors: Rossi, G.M.; Rocco, R.; Accorsi Buttini, E.; Marvisi, C.; Vaglio, A.
Source: Self-asserted source
Giovanni M. Rossi via Scopus - Elsevier

FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome.

Immunology letters
2017-11 | Journal article
DOI: 10.1016/j.imlet.2017.11.002
PMID: 29155175
Contributors: Rossi GM; Bonatti F; Adorni A; Alberici F; Bodria M; Bonanni A; Ghiggeri GM; Martorana D; Vaglio A
Source: Self-asserted source
Giovanni M. Rossi via Europe PubMed Central

Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome.

Autoimmunity reviews
2017-08 | Journal article
DOI: 10.1016/j.autrev.2017.07.020
PMID: 28780079
Contributors: Danlos FX; Rossi GM; Blockmans D; Emmi G; Kronbichler A; Durupt S; Maynard C; Luca L; Garrouste C; Lioger B et al.
Source: Self-asserted source
Giovanni M. Rossi via Europe PubMed Central

Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis.

Annals of the rheumatic diseases
2017-08 | Journal article
DOI: 10.1136/annrheumdis-2017-211897
PMID: 28814426
Contributors: Emmi G; Rossi GM; Urban ML; Silvestri E; Prisco D; Goldoni M; Vaglio A
Source: Self-asserted source
Giovanni M. Rossi via Europe PubMed Central

Peptide Receptor Radionuclide Therapy-Induced Gitelman-like Syndrome.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2017-07 | Journal article
DOI: 10.1053/j.ajkd.2017.05.024
PMID: 28739329
Contributors: Negro A; Rossi GM; Nicoli D; Versari A; Farnetti E; Santi R; De Pietri S
Source: Self-asserted source
Giovanni M. Rossi via Europe PubMed Central

Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature

Clinical Reviews in Allergy and Immunology
2016 | Journal article
DOI: 10.1007/s12016-016-8584-1
EID:

2-s2.0-84983390971
Contributors: Rossi, G.M.; Emmi, G.; Corradi, D.; Urban, M.L.; Maritati, F.; Landini, F.; Galli, P.; Palmisano, A.; Vaglio, A.
Source: Self-asserted source
Giovanni M. Rossi via Scopus - Elsevier

A Case of Severe Sprue-like Enteropathy Associated with Losartan

Journal of Clinical Gastroenterology
2015 | Journal article
DOI: 10.1097/MCG.0000000000000383
EID:

2-s2.0-84942154953
Contributors: Negro, A.; Rossi, G.M.; Santi, R.; Iori, V.; De Marco, L.
Source: Self-asserted source
Giovanni M. Rossi via Scopus - Elsevier

Peer review (9 reviews for 3 publications/grants)

Review activity for BMC nephrology (1)
Review activity for Internal and emergency medicine. (5)
Review activity for JN. Journal of Nephrology. (3)
How many people are using ORCID?